Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms

por Rice, K L, Lin, X, Wolniak, K, Ebert, B L, Berkofsky-Fessler, W, Buzzai, M, Sun, Y, Xi, C, Elkin, P, Levine, R, Golub, T, Gilliland, D G, Crispino, J D, Licht, J D, Zhang, W
Publicado 2011

P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION

por Zoref-Lorenz, A., Murakami, J., Hofstetter, L., Abadi, U., Iyer, S., Mohamed, S., Miller, P. G., Natour, A. E. H., Weinstein, S., Yacobovich, J., Izraeli, S., Nikiforow, S., Ebert, B., Gurion, R., Cohen, I., Pasvolsky, O., Raanani, P., Nagler, A., Berliner, N., Daver, N., Ellis, M., Jordan, M.
Publicado 2022